AOL Web Search

  1. About 36 search results
  1. Web results:
  2. BREAKING! U.S. NIH Funded Study Reveals Gloomy Findings About ...

    www.thailandmedical.news/news/breaking-u-s-nih...

    COVID-19 Immunology: A new study funded by the U.S. NIH along with the Melinda and Gates Foundation that has not been covered by the mainstream media has revealed very gloomy findings about the long-term protection from COVID-19 disease and actually bears warnings about possible ADE (Antibody-dependent enhancement) and autoimmune issues!

  3. Post-Vaccination Inflammatory Syndrome: a new syndrome - OAText

    www.oatext.com/post-vaccination-inflammatory...

    Since the post-vaccination adverse events (AEs) are related to the different period of life (childhood or adolescence), and to the different nervous area involved (brain or spinal cord); in this article we will deal with the regressive form of ASDs and present our hypothesis of a new post-vaccination inflammatory syndrome triggered by HPV vaccines.

  4. The Journal of Pediatrics is an international peer-reviewed journal that advances pediatric research and serves as a practical guide for pediatricians who manage health and diagnose and treat disorders in infants, children, and adolescents.

  5. Risk of myocarditis and pericarditis after the COVID-19 mRNA ...

    www.thelancet.com/journals/lancet/article...

    An increased risk of myocarditis or pericarditis was observed after COVID-19 mRNA vaccination and was highest in men aged 18–25 years after a second dose of the vaccine. However, the incidence was rare. These results do not indicate a statistically significant risk difference between mRNA-1273 and BNT162b2, but it should not be ruled out that a difference might exist. Our study results ...

  6. Before You Vaccinate Your Child, Consider Five Essential Issues

    rescue.substack.com/p/before-you-vaccinate-your...

    In support of vaccines for toddlers, the FDA pointed to a “ surge ” in childhood covid, with an ominous chart influenza disease. Finally, a just-published British Medical Journal opinion article concluded on childhood covid vaccination, “the vast majority stands little to benefit, and it is ethically dubious to pursue a hypothetical protection of adults while exposing children to harms ...

  7. Vaccine researcher admits ‘big mistake,’ says spike protein ...

    www.lifesitenews.com/news/vaccine-researcher-admi

    ‘Terrifying’ new research finds vaccine spike protein unexpectedly in bloodstream. The protein is linked to blood clots, heart and brain damage, and potential risks to nursing babies and ...

  8. Objectives To derive and validate risk prediction algorithms to estimate the risk of covid-19 related mortality and hospital admission in UK adults after one or two doses of covid-19 vaccination. Design Prospective, population based cohort study using the QResearch database linked to data on covid-19 vaccination, SARS-CoV-2 results, hospital admissions, systemic anticancer treatment ...

  9. SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced ...

    ard.bmj.com/content/early/2022/07/25/ard-2022-222689

    Objectives This study investigates whether COVID-19 vaccines can elicit cross-reactive antibody responses against the Omicron variant in patients with autoimmune rheumatic diseases (ARDs). Methods This observational cohort study comprised 149 patients with ARDs and 94 healthcare workers (HCWs). Blood samples were obtained at enrolment, a median of 15 weeks after the second vaccine dose or 8 ...

  10. 5 Facts to Consider Before Vaccinating Kids for COVID

    childrenshealthdefense.org/defender/covid...

    Even the CDC owned up in the Journal of the American Medical Association: Protection against Omicron for children 5 to 15, its study showed, was “modest and decreased rapidly.” A new Singapore study , addressed further below, found efficacy of two doses was 48.8% just one to two weeks after dual vaccination; it declined to 25.6% at two ...

  11. COVID‐19 vaccine effectiveness against hospitalization due to ...

    onlinelibrary.wiley.com/doi/10.1111/irv.13026

    In a study 28 in the United States between March and August 2021, in a population with a median age of 58, VE for Pfizer decreased from 91% (95% CI: 88–93%) between 14 and 120 days post-vaccination to 77% (95% CI: 67–84%) if >120 days post-vaccination, while VE for Spikevax remained high.